UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2735-2743

2014

Volltextzugriff (PDF)

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Journal of clinical oncology, 2018-05, Vol.36 (14), p.1412-1418

2018

Volltextzugriff (PDF)

OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma

Cancer, 2022-10, Vol.128 (19), p.3516-3522

2022

Volltextzugriff (PDF)

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002990

2021

Volltextzugriff (PDF)

Targeted therapies for the treatment of soft tissue sarcoma

Frontiers in oncology, 2023-03, Vol.13, p.1122508-1122508

2023

Volltextzugriff (PDF)

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

Frontiers in oncology, 2021-07, Vol.11, p.649963-649963

2021

Volltextzugriff (PDF)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Cancers, 2020-07, Vol.12 (7), p.1873

2020

Volltextzugriff (PDF)

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3766-3773

2007

Volltextzugriff (PDF)

Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma

Frontiers in oncology, 2023-01, Vol.13, p.1123464-1123464

2023

Volltextzugriff (PDF)

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3978-3984

2007

Volltextzugriff (PDF)

Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor

Gynecologic oncology reports, 2023-12, Vol.50, p.101294, Article 101294

2023

Volltextzugriff (PDF)

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

Cancer medicine (Malden, MA), 2023-01, Vol.12 (2), p.1532-1539

2023

Volltextzugriff (PDF)

Role of immunotherapy in chondrosarcoma: A case report and review of the literature

Therapeutic advances in medical oncology, 2023-01, Vol.15

2023

Volltextzugriff (PDF)

Surgical Management of Retroperitoneal Sarcoma

Current oncology (Toronto), 2023-04, Vol.30 (5), p.4618-4631

2023

Volltextzugriff (PDF)

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Cancer, 2012-03, Vol.118 (6), p.1486-1497

Agulnik, Mark

2012

Volltextzugriff (PDF)

Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index‐10 (FHNSI‐10)

Health science reports, 2021-12, Vol.4 (4), p.e401-n/a

2021

Volltextzugriff (PDF)

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy

Cancer medicine (Malden, MA), 2022-09, Vol.11 (18), p.3471-3478

2022

Volltextzugriff (PDF)

Evolving strategies for management of desmoid tumor

Cancer, 2022-08, Vol.128 (16), p.3027-3040

2022

Volltextzugriff (PDF)

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Drug design, development and therapy, 2016-01, Vol.10 (Issue 1), p.873-884

2016

Volltextzugriff (PDF)

Impact and Perceptions of Mandatory Tumor Biopsies for Correlative Studies in Clinical Trials of Novel Anticancer Agents

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4801-4807

2006

Volltextzugriff (PDF)

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma

Cancer medicine (Malden, MA), 2019-06, Vol.8 (6), p.2994-3003

2019

Volltextzugriff (PDF)

Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2184-2190

2007

Volltextzugriff (PDF)

Prices and Trends in FDA-Approved Medications for Sarcomas

Cancers, 2024-04, Vol.16 (8), p.1545

2024

Volltextzugriff (PDF)

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.882-893

2020

Volltextzugriff (PDF)

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A843-A843

2020

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(100)
Berichte
(2)

Sprache

Englisch
(102)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(102)
Journals@Ovid
(62)
Standalone journals
(58)
IngentaConnect Journals
(36)
IngentaConnect Journals
(31)
MEDLINE
(29)
Wiley Online Library - AutoHoldings Journals
(16)
Wiley Online Library Full Collection 2018
(8)
SpringerLink Series
(5)
Springer journals
(5)
Sage Journals
(4)
BMJ Publishing
(3)
Nature
(3)
Taylor & Francis Journals
(3)
Oxford Journals
(1)
Oxford Journals 2020 Medicine
(1)

11 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Targeted therapies for the treatment of soft tissue sarcoma

The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma

Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Underreporting of SMARCB1 alteration by clinical sequencing: Integrative patho-genomic analysis captured SMARCB1/INI-1 deficiency in a vulvar yolk sac tumor

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

Role of immunotherapy in chondrosarcoma: A case report and review of the literature

Surgical Management of Retroperitoneal Sarcoma

New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index‐10 (FHNSI‐10)

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy

Evolving strategies for management of desmoid tumor

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Impact and Perceptions of Mandatory Tumor Biopsies for Correlative Studies in Clinical Trials of Novel Anticancer Agents

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma

Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib

Prices and Trends in FDA-Approved Medications for Sarcomas

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Aktive Filter

Suchergebnisse filtern